CLASS III Drug recall · Reported 6 May 2020 · FDA Enforcement Report

Esomeprazole Magnesium Delayed Release Capsules USP, 40 mg* recalled

Dr. Reddy's Laboratories is recalling Esomeprazole Magnesium Delayed Release Capsules USP, 40 mg*, distributed nationwide in the US. The recall was initiated on 24 Apr 2020 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: C900642, Exp. 06/2020
NDC43598-509, 43598-510
Quantity recalled1752 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1256-2020
FDA event ID
85557
Recalling firm
Dr. Reddy's Laboratories, Princeton, NJ
Manufacturer
Dr. Reddy's Laboratories Inc
Classification
Class III
Status
Terminated
Recall initiated
24 Apr 2020
FDA classified
28 Apr 2020
Reported
6 May 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

24 Apr 2020Recall initiated by company
28 Apr 2020Classified by FDA+4 days
6 May 2020Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Discoloration: product contains brown pellets

Product as listed by the FDA

Esomeprazole Magnesium Delayed Release Capsules USP, 40 mg*, 1000-count bottles, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 INDIA, NDC 43598-510-10

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Why was it recalled?

Discoloration: product contains brown pellets

Which lots are affected?

Lot #: C900642, Exp. 06/2020

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Dr. Reddy's Laboratories

All 165

Other Esomeprazole recalls

All 14